The effect of finasteride in men with benign prostatic hyperplasia
- 1 February 2002
- journal article
- other
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 167 (2 Part 2) , 1102-1107
- https://doi.org/10.1016/s0022-5347(02)80349-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- The Clinical Effects of a 5α-Reductase Inhibitor, Finasteride, on Benign Prostatic HyperplasiaJournal of Urology, 1992
- The clinical development of a 5α-reductase inhibitor, finasterideThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Effects of Finasteride (MK-906), a 5α-Reductase Inhibitor, on Circulating Androgens in Male Volunteers*Journal of Clinical Endocrinology & Metabolism, 1990
- Serum prostate-antigen levels in patients with benign prosttic hypertrophy treated with leuprolideUrology, 1989
- Effect of MK‐906, a Specific 5α‐reductase Inhibitor, on Serum Androgens and Androgen Conjugates in Normal MenJournal of Andrology, 1989
- Mortality and Reoperation after Open and Transurethral Resection of the Prostate for Benign Prostatic HyperplasiaNew England Journal of Medicine, 1989
- Treatment of Benign Prostatic Hyperplasia by Androgen Deprivation: Effects on Prostate Size and Urodynamic ParametersJournal of Urology, 1989
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male PseudohermaphroditismScience, 1974
- Familial Incomplete Male Pseudohermaphroditism, Type 2New England Journal of Medicine, 1974